Showing results (481-490 of 590) with videos related to

Sort By:
Pageof 59
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|June 16, 2009
[Preoperative concomitant radiochemotherapy in bulky carcinoma of the cervix: Institut Curie experience]Y M Kirova, Z Bourhaleb, S Alran, et al.
British Journal of Cancer|February 7, 2008
High rates of breast conservation for large ductal and lobular invasive carcinomas combining multimodality strategiesM A Bollet, A Savignoni, J-Y Pierga, et al.
Hepatology (Baltimore, Md.)|June 2, 2007
Genome-level analysis of genetic regulation of liver gene expression networksDaniel Gatti, Akira Maki, Elissa J Chesler, et al.
Cancers|March 19, 2020
Maximizing the Clinical Benefit of Radiotherapy in Solitary Plasmacytoma: An International Multicenter AnalysisKhaled Elsayad, Michael Oertel, Laila König, et al.
European Radiology|February 7, 2025
Predicting axillary residual disease after neoadjuvant therapy in breast cancer using baseline MRI and ultrasoundCaroline Malhaire, Ozgun Umay, Vincent Cockenpot, et al.
International Journal of Cancer|November 28, 2008
Different outcome of invasive cervical cancer associated with high-risk versus intermediate-risk HPV genotypePatricia de Cremoux, Anne de la Rochefordière, Alexia Savignoni, et al.
Clinical Breast Cancer|November 30, 2019
Ductal Carcinoma in Situ: A French National Survey. Analysis of 2125 PatientsBruno Cutuli, Claire Lemanski, Brigitte De Lafontan, et al.
International Journal of Radiation Oncology, Biology, Physics|May 25, 2011
Locoregional treatment for breast carcinoma after Hodgkin's lymphoma: the breast conservation optionSophie Haberer, Lisa Belin, Romuald Le Scodan, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|February 21, 2012
[Breast conserving surgery in locoregional treatment of breast carcinoma after Hodgkin lymphoma]S Haberer, L Belin, R Le Scodan, et al.
Cancers|August 26, 2022
Different Prognostic Values of Tumour and Nodal Response to Neoadjuvant Chemotherapy Depending on Subtypes of Inflammatory Breast Cancer, a 317 Patient-StudyMaximilien Rogé, Julia Salleron, Youlia Kirova, et al.
Pageof 59